Publications and conferences
• Frequently lectures at national and international conferences, and has presented public lectures on the topics of about rheumatic diseases, food and mood, and osteoporosis• 1. Scott DL, Houssein DA, Laasonen L. Proposed modification to Larsen's scoring methods for hand and wrist radiographs. British Journal of Rheumatology 1995; 34: 56.
• 2. Houssien DA, McKenna S, Scott DL The Nottingham Health Profile as a measure of disease activity and outcome in RA. British Journal of Rheumatology 1997; 36: 69-73.• 3. Houssien DA, Jonsson T, E Davies, Scott DL. Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis. Journal of Rheumatology 1997; 24 : 2119-22• 4. Houssien DA, Jonsson T, E Davies, Scott DL. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis: comparative effects of different antigens. Scandinavian Journal of Rheumatology 1998; 27:46-53• 5. Lassere M, Houssein D, Scott DL, Edmonds J. Reference curves radiological damage in patients with rheumatoid arthritis: application of quintile regression and fractional polynomials. Journal of Rheumatology 1997; 24 (7): 1288-94.• 6. Houssien DA, Scott DL.Early referral and outcome in rheumatoid arthritis. Scandinavian Journal of Rheumatology 1998; 27(4): 300• 7. Houssien DA, Jonsson T, Scott DL. Smoking, rheumatoid factors and rheumatoid arthritis. Annals of Rheumatic Disease 1998; 57: 175-176• 8. Scott DL, Houssein DA. Joint assessment in rheumatoid arthritis. British Journal of Rheumatology 1996; 35(suppl. 2): 14-18.• 9. Scott DL, Houssein DA. Clinical and laboratory assessments in rheumatoid arthritis and osteoarthritis. British Journal of Rheumatology 1996; 35 suppl. 3: 6-9.• 10. Scott DL, Laasonen L, Priolo F, Houssein DA, Cerase A, Bacarini, Cammisa M. The radiological assessment of rheumatoid arthritis. Clinical and Experimental Rheumatology 1997; 15 (suppl 17): S53-S62.• 11. Houssien DA, Carr AJ. Techniques for health status measurement in the management of RA. BioDrugs. 1999; 11: 21-30.• 12. Sangha O, Houssien D, Stucki G. Standardized assessment of health status with self-administered patient questionnaires in rheumatic diseases. EULAR 1998; 27/1:21-24• 13. Houssien DA, Stucki G, Scott DL patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research. Rheumatology (Oxford). 1999; 38(1):48-52.• 14. Houssien DA, Stucki G, Scott DL Possibilita di sostituire un indice di attivita pathologica ricavato dal medico con uno ricavato dal paziente nella ricerca clinica (Italy). Rheumatology (Oxford). 1999; 3(2):13-18.• 15. Chung YL, Mitchell HL, Houssien DA, Al-Mahrouki H, Carr AJ, Scott DL A comparative study of outcome in myositis and other musculoskeletal disorders assessed using the Nottingham health profile. Clin Exp Rheumatol 2001; 19(4):447-50• 16. Steer S, Ibrahim F, Abozaid H, Pollard L, Khoshaba B, Houssien D, Lempp H, Scott DL The effects of ethnicity on disease activity and disability in rheumatoid arthritis. Clin Rheumatol 2010.• 17. Safi MA, Houssien DA, Scott DL Disease Activity and Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody in Saudi RF Negative RA Patients. Journal King Abdul-Aziz University: Med Sci 2012.; 19(3):3-20• 18.Houssein DA, Houssien AD. Proceedings of the 7th world congress of the international society of physical and rehabilitation medicine (ISPRM, Beijing, China, June 16-20, 2013: 163-165• 19. Safi MA, Houssien DA, Scott DL, Safi O. The clinical association of Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody in Patients with rheumatoid arthritis in Saudi Arabia. Journal of Autoimmunity 2014. 48-49:1-152.• 20. Mohammad-Ayman A Safi, Dhiya A Houssien. Serological Association with Extra-articular conditions in Saudi Rheumatoid Arthritis Patients. Medical Science, 2015, 16(65), 29-37.• 21. Scott IC, Ibrahim F, Safi M-A, Houssien D, Scott DL. The Erythrocyte Sedimentation Rate denotes 28-Joint Disease Activity Scores, but is not associated with Post-Treatment Disability and health –related quality of life. Rheumatology 2017: 56(suppl 2).• 22. Mohammad-Ayman A Safi, Dhiya A Houssien. Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor (Prevalence and Association) in Saudi Rheumatoid Arthritis Patients. Medical Sciences, 2018, 25 (2):1-10.• Over 100 publications on the subject of rheumatism in different Arabic newspapers and magazines in several countries (Saudi Arabia, United Arab Emirates, Kuwait, UK)• In addition to the 20 original papers in peer reviewed journals, he has published 53 abstracts in peer reviewed journals and presented them at 40 international meetings & conferences• 1- Houssien DA, Smith EC, Berry H, Scott DL. Cyclosporin therapy and the radiological progression of established rheumatoid arthritis. British Journal of Rheumatology 1994; 33: (suppl 2): 25.• 1- Houssien DA, Smith EC, Berry H, Scott DL. Cyclosporin therapy and the radiological progression of established rheumatoid arthritis. British Journal of Rheumatology 1994; 33: (suppl 2): 25.• 2- Houssien DA, Smith EC, Berry H, Scott DL. Cyclosporin therapy and X-ray progression in RA. Arthritis and Rheumatism 1994; 37 (suppl): S335.• 4- Lassere M, Edmonds J, Houssein D, Scott DL. Centile curves of radiological damage: rheumatoid arthritis population. British Journal of Rheumatology 1995; 34 (suppl 1): 106.• 5- Houssien DA, Choy EHS, Berry H, Scott DL. Health status and joint damage divergence in rheumatoid arthritis. British Journal of Rheumatology 1995; 34 (suppl 1): 107.• 6- Houssien DA, Choy EHS, Berry H, Scott DL. What quality of life assessments should be used in RA? British Journal of Rheumatology 1995; 34 (suppl 2): 11.• 7- Lassere M, Edmonds J, Houssien D, Scott DL. Reference centiles of radiological damage. Arthritis and Rheumatism 1995; 38 (suppl): S174.• 8- Houssien DA, Davies E, Jonsson T, Scott DL. IgA RF and disease activity in rheumatoid arthritis. Arthritis and Rheumatism 1995; 38 (suppl): S255.• 9- Houssien DA, Choy EHS, Berry H, Scott DL . Diverging health status and joint damage in rheumatoid arthritis. Rheumatology In Europe 1995; 24 (suppl 3): 203.• 10- Houssien DA, Choy EHS, Scott DL. The radiological progression and Cyclosporin in established rheumatoid arthritis. Rheumatology In Europe 1995; 24 (suppl 3): 232.• 11- Houssien DA, Choy EHS, Berry H. Scott DL. Comparison of generic and disease specific quality of life instruments to define disease outcome in RA. Rheumatology In Europe 1995; 24 (suppl 3): 384.• 12- Houssien DA, Jonsson T, Scott DL. RF isotypes in patients with RA; association with disease activity. Scandinavian Journal of Rheumatology 1996; (suppl 106): 19.• 13- Houssien DA, Jonsson T, Scott DL. Subclasses of IgA Rheumatoid factor in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 1996; (suppl 106): P 73: 57.• 14- Houssien DA, Jonsson T, Scott DL. Relation between radiological progression in rheumatoid arthritis and RF isotypes. Scandinavian Journal of Rheumatology 1996; (suppl 106): P 73: 57.• 15- Houssien DA, Vincent C, Serre G, Scott DL. Anti-keratin antibodies, disease activity and radiological damage in rheumatoid arthritis. British Journal of Rheumatology 1996; 35 (suppl 2): 14• 16- Houssien DA, Jonsson T, Scott DL. Rheumatoid factor isotypes and radiological progression in rheumatoid arthritis. British Journal of Rheumatology 1996; 35 (suppl 2): 14• 17.Houssien DA, Vincent C, Serre G, Scott DL. The relationship of anti-keratin antibodies to disease activity and radiological changes in rheumatoid arthritis• 18. Houssien DA, Jonsson T, Scott DL. Subclasses of IgA Rheumatoid factor in RA patients. Arthritis and Rheumatism 1996; 39 (suppl): 762/S154• 19. Houssien DA, Choy EHS, Berry H, Scott DL . Differences between the clinical and radiological progression of rheumatoid arthritis. British Journal of Rheumatology 1996; 35 (suppl 1):199.• 20. Houssien DA, Jonsson T, Scott DL. Rheumatoid factor isotypes: An association with radiological progression in RA British Journal of Rheumatology 1996; 35 (suppl 1): 207.• 21. Houssien DA, Comer M, Doyle D, Hopkins A, Scott DL. Early referral and outcome in rheumatoid arthritis. British Journal of Rheumatology 1996; 35 (suppl 1): 229.• 22. Houssien DA, Jonsson T, Scott DL. Association between radiological progression in RA and rheumatoid factors isotypes. The Iceland Medical Journal 1996; 82/31: 54.• 23. Houssien DA, McKenna S, Scott DL. Measuring disease activity and outcome in RA using the Nottingham Health Profile. British Journal of Rheumatology 1996; 35 (suppl 1): 231.• 24. Houssien DA, Jonsson T, Scott DL. IgA rheumatoid factor subclasses in patients with rheumatoid arthritis The Iceland Medical Journal 1996; 82/31: 54.• 25. Houssien DA, McKenna S, Scott DL. The Nottingham Health Profile as a measure of disease activity and outcome in RA Arthritis and Rheumatism 1996; 39 (suppl): 763/S154• 26. O’Donohue J, Smith EC, Houssien DA, Douds AC, Jonsson T, Williams R Arthritis in primary biliary cirrhosis: a clinical, radiological and immunological study Gastroenterology 1996; 110 (4): A1281• 27. Rojkovich B, Houssien DA, Greenwood M, Doyle DV, Scott DL HAQ is similar in follow-up RA cases across European centers British Journal of Rheumatology 1997; 36 (suppl 1): 51.• 28. Greenwood M, Houssien DA, Doyle DV, Scott DL What reflects patient-centered outcome in rheumatoid arthritis British Journal of Rheumatology 1997; 36 (suppl 1): 152.• 29. Houssien DA, Stucki G, Scott DL. Should patients with rheumatoid arthritis measure their disease activity ? British Journal of Rheumatology 1997; 36 (suppl 1): 153.• 30. Houssien DA, Whalley D, McKenna S, Scott DL. The value of health status measures in the assessment of RA British Journal of Rheumatology 1997; 36 (suppl 1): 150.• 31. Al-Mahrouki H, Carr A J, Houssien DA, Scott DL, Thomas S, Hewala A A comparison of self-reported health status in OA and RA Arthritis and Rheumatism 1997; 40 (suppl): 477/S110• 32. Chung YL, Houssien DA, Carr A J, Scott DL Health status in inflammatory muscle disease Arthritis and Rheumatism 1997; 40 (suppl):505/S115• 33. Houssien DA, Choy EH, Carr A J, Scott DL Rheumatoid arthritis (RA) outcome in routine practice: A comparison of outcome assessments Arthritis and Rheumatism 1997; 40 (suppl):726/S152• 34. Houssien DA, Stucki G, Scott DL. Should patients with rheumatoid arthritis (RA) measure their disease activity? Arthritis and Rheumatism 1997; 40 (suppl): 1529/S286• 35. Scott DL, Laasonen L, Priolo F, Houssien DA, Bacarini L, Cerase A, Cammisa M. The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol. 1997; 15 (suppl): 17/S53–S61.• 36. Houssien DA, Choy EH, Carr A J, Scott DL Rheumatoid arthritis (RA) outcome in routine practice: A comparison of outcome assessments British Journal of Rheumatology 1998; 37 (suppl 1): 251• 37. Chung YL, Houssien DA, Carr A J, Scott DL Health status in inflammatory muscle disease British Journal of Rheumatology 1998; 37 (suppl 1): 160• 38. Greenwood M, Scott DL, Carr A J, Deodhar A, Dolan L, Doyle DV, Houssien DA Pain and disability in RA Ann Rheum Dis 1999; 58(suppl): 91• 39..Houssien DA, T. Garrood, DL. Scott. Different clinical patterns of rheumatoid arthritis in saudi arabia and the uk. British Journal of Rheumatology 2000; 39 (suppl 1)• 40.Khoshaba BB, Houssien DA, Choy EH, Scott DL The Nottingham health Profile and health assessment questionnaire in assessing rheumatoid disability Rheumatology 2002; 41 (suppl 1):168• 41. Khoshaba BB, Houssien DA, Choy EH, Scott DL Relationship between disability measures using health assessment questionnaire and SF-36 Rheumatology 2002; 41 (suppl 1):170• 42. Houssein D, Khobasha B, Scott D L Disease activity scores and geographical variations of the clinical phenotype of RA: Comparing Saudi Arabia With England Journal of Rheumatology 2006; 9 (suppl 1): 183-4.• 43. Houssien D, Khoshaba B, Scott DL. Geographical variations in the clinical phenotype of rheumatoid arthritis: Comparing disease activity with Saudi Arabia and England. Rheumatology 2007; 46 (suppl 1): 94• 44.Houssein DA The relief of chronic low back pain immediately after one session of low level laser acupuncture therapy. Rheumatology 2007; 46 (suppl 1):124• 44.Houssein DA The relief of chronic low back pain immediately after one session of low level laser acupuncture therapy. Rheumatology 2007; 46 (suppl 1):124• 45.Houssein DA The relief of chronic low back pain immediately after one session of low level laser acupuncture therapy. Annals of the Rheumatic Diseases 2007; 239• 46.Houssein DA The relief of chronic low back pain immediately after one session of low level laser acupuncture Therapy. Photomedicine and Laser Surgery 2007, 25(4): 368-370.• 47.Houssein DA The relief of back pain immediately after one session of low level laser acupuncture therapy (lllt): European journal pain. September, 2009, 21 (suppl 1): S35• 48.Safi MA, Houssien DA, Scott DL. Disease Activity and Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody in Saudi RF- Negative RA Patients. Journal of King Abdulaziz University, 2012, 19.3: 3-20.• 49- Safi MA, Houssien DA, Scott DL, Safi O. The clinical association of Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody in Patients with RA in Saudi Arabia. Journal of Autoimmunity 2014. 48-49:1-152.• 50. Safi MA, Houssien DA Serological Association with Extra-articular conditions in Saudi Rheumatoid Arthritis Patients Medical Science, 2015, 16(65), 29-37,• 51. Scott IC, Ibrahim F, Safi MA, Houssien DA, Scott DL The ESR dominates DAS28 scores, but is not associated with post-treatment disability and health-related quality of life. Rheumatology 2017, 56 (suppl 2):• 52.Houssien D, Houssien A The relief of chronic low back pain(CLBP)immediately after one session of low level laser acupuncture therapy. Annals of rheumatic disease, 2018 Volume 77, Issue Suppl 2:468• 53. Houssien D A sustainable relief of chronic low back pain immediately after a session of LLLAT Clinical and Experimental Rheumatology 2018, S44• 54. Houssien Amru, Houssein Dhiya. A sustainable relief of chronic back pain after one session of low level laser acupuncture therapy. Alternative & Integrative Medicine journal 2019 Volume 8:27
...
Todas las valoraciones son de pacientes reales y las opiniones han sido verificadas por nuestro departamento de Atención al Paciente para garantizar que cumplen con las normas del servicio.
Videoconferencia:
£200
Patient reviews
M. Verified Patient
01/07/2024
Would you recommend this doctor?
Patients comments
I was suffering for many years now with multiple things and Dr. Houssien is the first to tell me what’s wrong and what I need to do. I will definitely be traveling to London from America to continue treatment with him!!!
S H. Verified Patient
01/07/2024
Would you recommend this doctor?
Patients comments
Very Professional & amazing doctor with Excellent care , really I was so impressed
M. Verified Patient
30/06/2024
Would you recommend this doctor?
Patients comments
Excellent experience thanks professor Dr Dhiya ❤️ Mohamed Elshemy
O M. Verified Patient
30/06/2024
Would you recommend this doctor?
Patients comments
Dr deyaa very good character and listening for me and more information about cases